Antisense modulation of fibroblast growth factor receptor 2 expression
First Claim
1. A compound 8 to 50 nucleobases in length targeted to nucleobases 1479 through 1508 of a coding region of a nucleic acid molecule encoding human fibroblast growth factor receptor 2, wherein said compound is an antisense oligonucleotide, wherein said antisense oligonucleotide comprises at least one modified internucleoside linkage, and wherein said compound specifically hybridizes with said nucleic acid molecule encoding human fibroblast growth factor receptor 2 (SEQ ID NO:
- 3) and inhibits the expression of human fibroblast growth factor receptor 2.
1 Assignment
0 Petitions
Accused Products
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 2. Methods of using these compounds for modulation of fibroblast growth factor receptor 2 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 2 are provided.
9 Citations
11 Claims
-
1. A compound 8 to 50 nucleobases in length targeted to nucleobases 1479 through 1508 of a coding region of a nucleic acid molecule encoding human fibroblast growth factor receptor 2, wherein said compound is an antisense oligonucleotide, wherein said antisense oligonucleotide comprises at least one modified internucleoside linkage, and wherein said compound specifically hybridizes with said nucleic acid molecule encoding human fibroblast growth factor receptor 2 (SEQ ID NO:
- 3) and inhibits the expression of human fibroblast growth factor receptor 2.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
Specification